Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 1
2004 1
2005 5
2006 1
2007 2
2009 3
2010 8
2011 14
2012 26
2013 27
2014 22
2015 25
2016 43
2017 42
2018 47
2019 52
2020 54
2021 86
2022 79
2023 56
2024 86
2025 18

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

615 results

Results by year

Filters applied: . Clear all
Page 1
Integrating spatial and single-cell transcriptomics to characterize the molecular and cellular architecture of the ischemic mouse brain.
Han B, Zhou S, Zhang Y, Chen S, Xi W, Liu C, Zhou X, Yuan M, Yu X, Li L, Wang Y, Ren H, Xie J, Li B, Ju M, Zhou Y, Liu Z, Xiong Z, Shen L, Zhang Y, Bai Y, Chen J, Jiang W, Yao H. Han B, et al. Among authors: ren h. Sci Transl Med. 2024 Feb 7;16(733):eadg1323. doi: 10.1126/scitranslmed.adg1323. Epub 2024 Feb 7. Sci Transl Med. 2024. PMID: 38324639
Nomogram predicting bullying victimization in adolescents.
Lv J, Ren H, Guo X, Meng C, Fei J, Mei H, Mei S. Lv J, et al. Among authors: ren h. J Affect Disord. 2022 Apr 15;303:264-272. doi: 10.1016/j.jad.2022.02.037. Epub 2022 Feb 15. J Affect Disord. 2022. PMID: 35176341
Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial.
Gao X, Xu N, Li Z, Shen L, Ji K, Zheng Z, Liu D, Lou H, Bai L, Liu T, Li Y, Li Y, Fan Q, Feng M, Zhong H, Huang Y, Lou G, Wang J, Lin X, Chen Y, An R, Li C, Zhou Q, Huang X, Guo Z, Wang S, Li G, Fei J, Zhu L, Zhu H, Li X, Li F, Liao S, Min Q, Tang L, Shan F, Gong J, Gao Y, Zhou J, Lu Z, Li X, Li J, Ren H, Liu X, Yang H, Li W, Song W, Wang ZM, Li B, Xia M, Wu X, Ji J. Gao X, et al. Among authors: ren h. Lancet Oncol. 2023 Oct;24(10):1134-1146. doi: 10.1016/S1470-2045(23)00411-4. Lancet Oncol. 2023. PMID: 37797632 Clinical Trial.
A generalist vision-language foundation model for diverse biomedical tasks.
Zhang K, Zhou R, Adhikarla E, Yan Z, Liu Y, Yu J, Liu Z, Chen X, Davison BD, Ren H, Huang J, Chen C, Zhou Y, Fu S, Liu W, Liu T, Li X, Chen Y, He L, Zou J, Li Q, Liu H, Sun L. Zhang K, et al. Among authors: ren h. Nat Med. 2024 Nov;30(11):3129-3141. doi: 10.1038/s41591-024-03185-2. Epub 2024 Aug 7. Nat Med. 2024. PMID: 39112796
Cadonilimab with chemotherapy in HER2-negative gastric or gastroesophageal junction adenocarcinoma: the phase 1b/2 COMPASSION-04 trial.
Gao X, Ji K, Jia Y, Shan F, Chen Y, Xu N, Jia Z, Liu T, Yang N, Zhong H, Li C, Guo Z, Fan Q, Lin X, Zhang Y, Ren H, Yang H, Yao Z, Liu W, Wang ZM, Li B, Xia M, Shen L, Li Z, Ji J. Gao X, et al. Among authors: ren h. Nat Med. 2024 Jul;30(7):1943-1951. doi: 10.1038/s41591-024-03007-5. Epub 2024 May 22. Nat Med. 2024. PMID: 38778212 Clinical Trial.
615 results